Skip to main content
. 2023 Oct 30;149(1):28–35. doi: 10.1161/CIRCULATIONAHA.123.066213

Figure 2.

Figure 2.

Inflammation determines risk of cardiovascular death at both high and low levels of LDLC. Joint analysis of hsCRP (≥ or <2 mg/L) and LDLC (≥ or <130 mg/dL) as predictors of cardiovascular death among 13 970 statin-intolerant patients. Hazard ratios and 95% CIs adjusted for age, sex, ethnicity, region, diabetes, body mass index, estimated glomerular filtration rate, blood pressure, alcohol use, smoking status, known atherosclerotic disease, and randomized treatment assignment. hsCRP indicates high-sensitivity C-reactive protein; and LDLC, low-density lipoprotein cholesterol.